These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16977278)

  • 21. Cardiac repolarization and the safety of new drugs defined by electrocardiography.
    Morganroth J
    Clin Pharmacol Ther; 2007 Jan; 81(1):108-13. PubMed ID: 17186008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic studies in hemodialysis patients.
    Atkinson AJ; Umans JG
    Clin Pharmacol Ther; 2009 Nov; 86(5):548-52. PubMed ID: 19675540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the ethics of clinical trials of new drugs].
    Leshchinskiĭ LA
    Klin Med (Mosk); 1999; 77(6):50-1. PubMed ID: 10459222
    [No Abstract]   [Full Text] [Related]  

  • 24. NEW DRUGS 09: part 1.
    Hussar DA
    Nursing; 2009 Feb; 39(2):41-9; quiz 49-50. PubMed ID: 19158644
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolism and pharmacokinetics in children and the elderly.
    Pelkonen O
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-interventional studies give good follow-up possibilities. Increased demand both nationally and internationally can be predicted].
    Strandberg K
    Lakartidningen; 2007 Sep 12-18; 104(37):2597-9. PubMed ID: 17970395
    [No Abstract]   [Full Text] [Related]  

  • 27. [Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years].
    Glazer A; Hedenmalm K
    Lakartidningen; 2008 Sep 10-16; 105(37):2482-4. PubMed ID: 19006863
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug delivery in the twenty-first century: a new paradigm.
    Smith B; Uhl K
    Clin Pharmacol Ther; 2009 May; 85(5):451-5. PubMed ID: 19381145
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs in pregnancy: acknowledging challenges--finding solutions.
    Koren G; MacLeod S; Davis D
    Can J Clin Pharmacol; 2007; 14(1):e2-4. PubMed ID: 17213506
    [No Abstract]   [Full Text] [Related]  

  • 30. Tablet splitting.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):62-3. PubMed ID: 19661854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)].
    Vos EJ; Huitema AD
    Ned Tijdschr Geneeskd; 2006 Sep; 150(38):2104-7. PubMed ID: 17036864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
    Gwathmey JK; Tsaioun K; Hajjar RJ
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):647-60. PubMed ID: 19442031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacovigilance in India: how safe are the new drugs? How sure are we?
    Joshi SR; Sapatnekar SM
    J Assoc Physicians India; 2008 Dec; 56():933-4. PubMed ID: 19322970
    [No Abstract]   [Full Text] [Related]  

  • 35. Dose finding - a challenge in statistics.
    Bretz F; Hsu J; Pinheiro J; Liu Y
    Biom J; 2008 Aug; 50(4):480-504. PubMed ID: 18663758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drugs: 10 years of recall from the market].
    Bouvier-Colle MH
    Rev Epidemiol Sante Publique; 1994; 42(5):466-7. PubMed ID: 7973007
    [No Abstract]   [Full Text] [Related]  

  • 37. Nephropharmacology: drugs and the kidney.
    Atkinson AJ; Huang SM
    Clin Pharmacol Ther; 2009 Nov; 86(5):453-6. PubMed ID: 19844216
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary on ACCP position statement on the use of microdosing in the drug development process.
    Rowland M
    J Clin Pharmacol; 2007 Dec; 47(12):1595-6; author reply 1597-8. PubMed ID: 18048576
    [No Abstract]   [Full Text] [Related]  

  • 39. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.
    Wong J; Brugger A; Khare A; Chaubal M; Papadopoulos P; Rabinow B; Kipp J; Ning J
    Adv Drug Deliv Rev; 2008 May; 60(8):939-54. PubMed ID: 18343527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling of the blood-brain barrier in drug discovery and development.
    Cecchelli R; Berezowski V; Lundquist S; Culot M; Renftel M; Dehouck MP; Fenart L
    Nat Rev Drug Discov; 2007 Aug; 6(8):650-61. PubMed ID: 17667956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.